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DOI: 10.1039/c1an15315cThe reaction of a fluorinated iridium complex with cerium(IV) and
organic reducing agents generates an intense emission with
a significant hypsochromic shift compared to contemporary chemi-
cally-initiated luminescence from metal complexes.The chemiluminescent reduction of tris(2,20-bipyridine)ruthenium(III)
([Ru(bipy)3]
3+) has been widely used to detect amines of medical,
forensic and industrial importance.1,2 In these reactions, the stable
[Ru(bipy)3]
2+ precursor is initially oxidised to [Ru(bipy)3]
3+, which is
then reduced by the analyte to the electronically excited [Ru(bipy)3]
2+*
species responsible for the emission.3 The reactive Ru(III) state can be
generated either chemically or electrochemically, where the overall
process is classified as chemiluminescence (CL),1,2 or electro-
chemiluminescence (ECL).4–7 The ECL of biomolecules labelled with
[Ru(bipy)3]
2+, in the presence a co-reactant such as tripropylamine,
has been utilised for exceedingly sensitive detection in commercial
immunoassay systems for clinical diagnostics, food and water testing,
and biodefence applications.6–8
The success of [Ru(bipy)3]
2+ CL/ECL has stimulated considerable
interest in developing new metal-complex reagents,9 although
research to date has predominantly focussed on ECL. One of the
most promising areas of investigation is cyclometalated iridium(III)
complexes, which exhibit relatively high photoluminescence efficien-
cies, appropriate ground and excited state redox potentials, and
a diverse range of emission wavelengths.5,6,10 The ECL of numerous
such complexes has been explored in both aqueous and organic
solvents.11–16 For example, Kapturkiewicz et al. reported very high
efficiencies for annihilation and organic co-reactant ECL of Ir(ppy)3
and L2Ir(acac) complexes (where L are various ligands with N and
C20 chelating atoms) in1 : 1 acetonitrile:dioxetane.11,12‡ Richter’s
group, however, found that the ECL efficiencies of Ir(ppy)3 andaSchool of Life and Environmental Sciences, Deakin University, Geelong,
Victoria, 3217, Australia. E-mail: paul.francis@deakin.edu.au
bCenter for in vitro Diagnostic Technologies, Suzhou Institute of Nano-
Tech and Nano-Bionics, Chinese Academy of Sciences, 398 Ruoshui
Road, Suzhou Industrial Park, Suzhou, Jiangsu, 215123, P. R. China.
† Electronic supplementary information (ESI) available: Absorption and
photoluminescence emission spectra for [(df-ppy)2Ir(BPS)]
, [(ppy)2Ir
(BPS)], and [Ru(bipy)3]
2+, intensity versus time profiles for the
chemiluminescence reactions of [(df-ppy)2Ir(BPS)]
 and [Ru(bipy)3]
2+
with cerium(IV) and ofloxacin, and NMR characterisation of
[(df-ppy)2Ir(BPS)]
 and [(ppy)2Ir(BPS)]
. See DOI: 10.1039/c1an15315c
This journal is ª The Royal Society of Chemistry 2011(btp)2Ir(acac) were orders of magnitude lower in more analytical
useful acetonitrile:water (1 : 1) and water solvents (with tripropyl-
amine as co-reactant), in which these neutral complexes have very
limited solubility.13,14
Kim et al. reported that ECL intensities for cationic [(ppy)2Ir
(bipy)]+ and [(ppy)2Ir(phen)]
+ complexes (prepared as PF6
 salts)
were six- and twelve-times greater than that of Ir(ppy)3 in polar
organic solvents using tripropylamine as a co-reactant,15 and we
subsequently utilised the more water-soluble chloride salts of these
complexes, and the sodium salt of the corresponding 4,7-diphenyl-
phenanthroline-disulfonate (bathophenanthroline disulfonate) deriv-
ative, [(ppy)2Ir(BPS)]
 (Fig. 1), in the first demonstration of
chemically initiated luminescence of cyclometalated iridium
complexes.17The [(ppy)2Ir(BPS)]
 complex in particular produced far
greater chemiluminescence intensities than [Ru(bipy)3]
2+, arising from
reaction of the oxidised [(ppy)2Ir(BPS)]
0 species with both analyte and
solvent.17 A related approach to improve the solubility in aqueous
solution for co-reactant ECL was recently described by Li et al.,18
who utilised a bis-cyclometalated iridium complex containing
a bipyridine ligand appended with two sugar moieties. The [(pq)2Ir
(bipy-sugar)]+ complex was evaluated using tripropylamine at a Pt
electrode, and found to produce an emission five-fold greater than
that of [Ru(bipy)3]
2+.
In contrast to the limited emission wavelengths available for
ruthenium polypyridine chelates,19 cyclometalated iridium complexes
can be ‘tuned’ across awide spectral range, as demonstrated in several
elegant photoluminescence studies.20–22 The ability to tune spectro-
scopic and redox properties through subtle changes in ligand struc-
ture is of great interest in CL/ECL analysis, in order to manipulate
the selectivity, shift emission wavelengths to more sensitive regions of
the photodetector, and enable simultaneous detection ofFig. 1 Structure of [(ppy)2Ir(BPS)]
 and [(df-ppy)2Ir(BPS)]
 complexes.
Analyst, 2011, 136, 3069–3072 | 3069
Fig. 2 Chemiluminescence from the reactions of (a) [(ppy)2Ir(BPS)]

and (b) [(df-ppy)2Ir(BPS)]
, with cerium(IV) and ofloxacin within a dual-
inlet serpentine flow-cell. Photographs taken using a Nikon D700 digital
camera, with 42 s and 30 s exposure time, respectively.
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View Onlinecomplementary chemiluminophores, for internal standardisation or
multi-analyte detection.13,14,19
Although the archetypal tris-cyclometalated iridium complex
Ir(ppy)3 exhibits green luminescence (lmax ¼ 517 nm, uncor-
rected) in acetonitrile at room temperature,13 substitution of one
phenylpyridine for bipyridine or other diimine ligand results in
a significant bathochromic shift,17,18,23,24 and thus complexes such
as [(ppy)2Ir(bipy)]
+ and [(ppy)2Ir(BPS)]
 emit orange light in
a similar region to that of [Ru(bipy)3]
2+. In contrast, the incor-
poration of electron-withdrawing substituents such as fluorine
on the cyclometalating ring causes a hypsochromic shift, by
stabilising the HOMO level.10,21,22,25 We have therefore adopted
this strategy to prepare an iridium-based chemiluminescence
reagent, [(df-ppy)2Ir(BPS)]
 (Fig. 1), with much shorter emission
wavelengths than the conventional [Ru(bipy)3]
2+ complex.x
The presence of the fluorine groups on [(df-ppy)2Ir(BPS)]
 lowered
the solubility of the complex in aqueous solution, and therefore the
reagents were prepared in 1 : 1 acetonitrile:water. The UV-vis
absorption spectra of [(df-ppy)2Ir(BPS)]
, [(ppy)2Ir(BPS)]
, and [Ru
(bipy)3]
2+ in this solvent mixture are included in the ESI (Fig. S1).†
The spectra were similar to those of the analogous complexes without
sulfonate substituents, [(df-ppy)2Ir(dpp)]
+ and [(ppy)2Ir(dpp)]
+, dis-
solved in acetonitrile,26 for which the strong bands below 300 nm
were attributed to intra-ligand p–p* transitions and the weaker,
poorly defined bands above 300 nm were ascribed to metal-to-ligand
charge transfer transitions. The photoluminescence of [(ppy)2Ir
(BPS)] in 1 : 1acetonitrile:water was similar to that of [Ru(bipy)3]
2+,
but the emission from [(df-ppy)2Ir(BPS)]
 was hypsochromically
shifted (Table 1 and Fig. S1 in ESI†). The photoluminescence
quantum yields of [(ppy)2Ir(BPS)]
 and [(df-ppy)2Ir(BPS)]
 were 3.4-
and 2.5-fold that of [Ru(bipy)3]
2+.{
Visual inspection of the reaction of [(df-ppy)2Ir(BPS)]
 with
cerium(IV) and a pharmaceutical (ofloxacin) when the reactants were
continuously merged within a serpentine flow-cell27 revealed
a striking green emission (Fig. 2).k Subsequent investigations were
performed using flow-injection analysis (FIA), where the reagent was
injected into a carrier stream containing an analyte, which merged
with the oxidant solution, before entering a coiled-tubing detection
cell.**
Using a reagent concentration (1  103 M) within the range
previously utilised for [Ru(bipy)3]
2+ (1  104 M to 2.5  103
M28–34), greater chemiluminescence signals were obtained using at
least one of the two iridium complexes for each analyte (Table 2).
However, the ‘blank’ responses (resulting from reaction of theTable 1 Spectroscopic data
Complex lAbs (nm)
a
lPL (nm)
a lCL (nm)
b
uncorr. corr. uncorr. corr.
[Ru(bipy)3]
2+ 286, 451 611 623 609 622
[(ppy)2Ir(BPS)]
 280 598 621 604 628
[(df-ppy)2Ir(BPS)]
 278 530 545 529 547
a Absorption and photoluminescence emission spectra obtained using 10
mM complex in 1 : 1 acetonitrile:water. b Chemiluminescence spectra
obtained by continuously merging a solution of reagent (0.5 mM) and
analyte (5 mM) with a solution of cerium(IV) (1 mM in 0.05 M H2SO4)
within a coiled reaction flow-cell mounted against the emission window
of a fluorescence spectrophotometer.
3070 | Analyst, 2011, 136, 3069–3072oxidised complexes with the solvent33) were also larger, resulting in
inferior signal/blank ratios. Interestingly, at lower reagent concen-
trations, this discrepancy was much smaller (Table 3), and in the case
of furosemide, the signal/blank ratio using [(df-ppy)2Ir(BPS)]
 was
superior to that obtained using [Ru(bipy)3]
2+.
The competing reactions of the reagent with target analyte and
solvent were further explored by monitoring the chemiluminescence
under stopped-flow conditions.** At a reagent concentration of 1
103 M, emission intensities for the reactions of 1 105 M ofloxacin
with [Ru(bipy)3]
2+ and [(df-ppy)2Ir(BPS)]
 (and 1  103 M cerium
(IV)) peaked at 6.9 s and 2.2 s from the initiation of the reaction, and
similar maxima were observed for the corresponding blank signals
(see ESI, Fig. S2a and S2b).† Lowering the reagent concentration to
1  105 M (and the analyte to 1  106 M) had little effect on the
shape of the profiles for [Ru(bipy)3]
2+ (other than a large decrease in
overall intensity). In the case of [(df-ppy)2Ir(BPS)]
, the profile for the
analyte signal was similar to that obtained at higher reagent condi-
tions, but the blank reponse contained a small initial sharp peak and
a relativly slow rise and decay over the next 80 s (Fig. S2c and S2d).†
It should be borne in mind that the light detected in an FIA system
(such as those reported in Tables 2 and 3) is only a portion of the
entire emisssion profile, dependant on the kinetics of the light-
producing pathway, the solution flow rates, and the volume and
geometry of the detection flow-cell. As the flow rates were optimised
for the greatest signal/blank ratios, the improved relationship at low
reagent concentrations can in part be explained by the relative rates of
reaction.
Calibrations for furosemide and ofloxacin using FIA with
0.01 mM [(df-ppy)2Ir(BPS)]
 gave limits of detection that were an
order of magnitude superior to those obtained with the same
concentration of [Ru(bipy)3]
2+ (Table 4), although in the case ofTable 2 Chemiluminescence signal (V) and signal/blank ratio (shown in
parentheses) for the reaction of 1 mM reagent with 1 mM Ce(IV) and
10 mM analyte
Analyte [Ru(bipy)3]
2+
[(ppy)2Ir
(BPS)]
[(dfppy)2Ir
(BPS)]
Oxalate 16 (319) 75 (4.8) 13 (3.5)
codeine 14 (205) 19 (1.3) 7 (2.1)
furosemide 4 (75) 21 (1.5) 120 (35)
ofloxacin 85 (1695) 37 (2.6) 304 (88)
This journal is ª The Royal Society of Chemistry 2011
Table 3 Chemiluminescence signal (mV) and signal/blank ratio for the
reaction of 10 mM reagent with 1 mM Ce(IV) and 1 mM analyte
Analyte [Ru(bipy)3]
2+
[(ppy)2Ir
(BPS)]
[(df-ppy)2Ir
(BPS)]
oxalate 0.8 (10) 2.3 (1.2) 0.1 (1.0)
codeine 0.4 (6) 5.1 (0.9) 0.1 (1.0)
furosemide 1.3 (17) 6.8 (3.6) 5.3 (73)
ofloxacin 3.2 (45) 6.2 (3.3) 1.9 (27)
Table 4 Limits of detection (blank + 3s) for two pharmaceuticals using
flow injection analysis with chemiluminescence detection
Reagenta ofloxacin (M) furosemide (M)
[Ru(bipy)3]
2+ 1 mM 1.1  109 4.3  107
0.01 mM 3.0  108 1.1  107
[(df-ppy)2Ir(BPS)]
 1 mM 1.9  108 2.5  108
0.01 mM 5.2  109 1.1  108
a Reagent injected into the analyte stream and merged with cerium(IV).
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View Onlineofloxacin, the best figure was obtained using 1 mM [Ru(bipy)3]
2+.
These limits of detection were comparable to those previously
reported for ofloxacin28–32 and furosemide33–35 using [Ru(bipy)3]
2+–Ce
(IV) chemiluminescence, which ranged from 1 109 M to 6 107
M, and from 8  109 M to 2  107 M, respectively.Conclusions
A heteroleptic iridium complex soluble in an analytically useful polar
solvent and exhibiting efficient green luminescence was attained
through a combination of fluorinated phenylpyridine and sulfonated
diphenylphenanthroline ligands. The [(df-ppy)2Ir(BPS)]
 complexwas
successfully utilised in chemiluminescence reactions with cerium(IV)
and organic analytes. Exploration of reaction conditions revealed that
the optimum reagent concentration is lower than that of the conven-
tional [Ru(bipy)3]
2+ complex, in part arising from differences in the
kinetics of their light-producing pathways. Modification of ligand
structure also influenced the relative sensitivity of the reagents towards
eachanalyte (for example,using1 105M[Ru(bipy)3]2+, the response
for ofloxacinwas 2.6-fold that for furosemide, but the relationshipwas
reversed using 1  105 M [(df-ppy)2Ir(BPS)]), which demonstrates
the potential to tune not only the photophysical properties of the
reagent, but also its reactivity towards the target analyte, to further
enhance the sensitivty and selectivity of chemiluminescence detection.Acknowledgements
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